New Key Statistics Module, Z-Score and F-Score
OTCPK:HNSBF Key Ratios
Market Cap $ M | 348.86 |
Enterprise Value $ M | 375.16 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 17.60 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 15.00 |
EPS (TTM) $ | -1.37 |
Beneish M-Score | -2.01 |
10-y EBITDA Growth Rate % | -34.60 |
5-y EBITDA Growth Rate % | -15.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -5.91 |
EV-to-EBITDA | -5.91 |
PEG | -- |
Shares Outstanding M | 67.76 |
Net Margin (%) | -490.11 |
Operating Margin % | -444.56 |
Pre-tax Margin (%) | -489.80 |
Quick Ratio | 3.04 |
Current Ratio | 3.05 |
ROA % (ttm) | -74.07 |
ROE % (ttm) | -- |
ROIC % (ttm) | -168.61 |
Dividend Yield % | -- |
Altman Z-Score | 0.41 |
HNSBF Number of Guru Trades
HNSBF Volume of Guru Trades
Gurus Latest Trades with OTCPK:HNSBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:HNSBF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hansa Biopharma AB Insider Transactions
No Available Data
News about OTCPK:HNSBF
Total 0- 1